GGrantIndex
Sort

23,748 grants matching melanoma

Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors

$359,256
Michael Lim · Stanford University · R01 · FY2023 · CA

A NON INVASIVE DERMATOLOGICAL LESION CLASSIFIER

$359,255
Western Research Company, Inc. · R44 · FY2001 · CA

Targeting macrophages in metastatic cancer

$359,162
Anthony Rongvaux · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

The Role of Stromal Autophagy in Cutaneous Melanoma

$359,148
Hilary A Coller · University Of California Los Angeles · R01 · FY2021 · CA

Project 2: The Impact of Immunotherapy on Human Vaccination

$359,130
E. John Wherry · Massachusetts General Hospital · U19 · FY2021 · AI

Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response

$359,100
Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2024 · CA

Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF

$359,035
Dario Marchetti · University Of New Mexico Health Scis Ctr · R01 · FY2022 · CA

Non-deletional CD8 T cell self-tolerance

$359,018
Stephen C Jameson · University Of Minnesota · P01 · FY2023 · AI

Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF

$359,008
Dario Marchetti · University Of New Mexico Health Scis Ctr · R01 · FY2023 · CA

Peptide Vaccination Targeting Tumor-Specific IDH1R132H Mutation for Brain Tumors

$358,971
John H Sampson · Duke University · P50 · FY2018 · CA

Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)

$358,935
Daphne A. Haas-Kogan · Brigham And Women'S Hospital · P50 · FY2021 · CA

Time Resolved Fluorescence Spectroscopy

$358,918
Jay R Knutson · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Spectroscopic dye localization: sentinel lymph nodes

$358,890
Spectros Corporation · R44 · FY2003 · CA

Targeting ROS by a p53-activating agent for selective killing of cancer cells

$358,877
Sam W Lee · Massachusetts General Hospital · R01 · FY2010 · CA

Endothelial plasticity in glioma vascularization and therapy resistance

$358,875
Yi Fan · University Of Pennsylvania · R01 · FY2025 · NS

Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy

$358,773
Matthias Gromeier · Duke University · R01 · FY2024 · CA

Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis

$358,756
Alexander D Boiko · University Of California-Irvine · R01 · FY2020 · CA

Control of Alphavirus Replication in the Nervous System

$358,750
Diane E Griffin · Johns Hopkins University · R01 · FY2008 · NS

DNA and protein reactions of NO', ONOO-, and reactive species produced by phagocy

$358,717
Peter C Dedon · Massachusetts Institute Of Technology · P01 · FY2009 · CA

Identification of Druggable Targets to Complement Melanoma Therapy

$358,700
Alan Jackson Tackett · Univ Of Arkansas For Med Scis · R01 · FY2019 · CA

Macrophage-based ovarian cancer immunotherapy

$358,694
Fiona E Yull · Vanderbilt University · R01 · FY2020 · CA

Multifunctional nanoparticles for targeting aberrant tumorigenic pathways

$358,689
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2011 · CA

Macrophage-based ovarian cancer immunotherapy

$358,683
Fiona E Yull · Vanderbilt University · R01 · FY2018 · CA

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$358,680
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Cancer biology in the zebrafish

$358,651
Leonard I Zon · Boston Children'S Hospital · R01 · FY2014 · CA